This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:protocol:olmesartan:kidney_disease [03.27.2017] – [Further reading] sallieq | home:protocol:olmesartan:kidney_disease [10.25.2018] – [Benefits of angiotensin receptor blockers] sallieq | ||
---|---|---|---|
Line 84: | Line 84: | ||
Olmesartan also has [[home: | Olmesartan also has [[home: | ||
- | {{tag> | + | {{tag> |
==== Animal studies ==== | ==== Animal studies ==== | ||
Line 92: | Line 92: | ||
Ability of Olmesartan to ameliorate renal injury and fibrosis in rats when taken at ultrahigh doses.(({{pubmed> | Ability of Olmesartan to ameliorate renal injury and fibrosis in rats when taken at ultrahigh doses.(({{pubmed> | ||
+ | |||
+ | {{tag> | ||
===== Notes and comments ===== | ===== Notes and comments ===== | ||
- | --- //Sallie Q 02.03.2017// | ||
* Legacy content | * Legacy content |